Singapore markets closed

Straits Times Index
3,362.99
-14.66(-0.43%)
S&P 500
4,119.21
+42.61(+1.05%)
Dow
34,092.96
+6.92(+0.02%)
Nasdaq
11,816.32
+231.77(+2.00%)
BTC-USD
23,777.94
+767.38(+3.33%)
CMC Crypto 200
542.52
+299.84(+123.55%)

PAVmed Inc. (PAVM)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

0.5120

+0.0007

(+0.14%)

At close: 04:00PM EST

0.5376

+0.03

(+5.00%)

After hours:

06:07PM EST

Trade prices are not sourced from all markets

All

Business Wire
PAVmed and Lucid Diagnostics Provide Strategic Business Update
NEW YORK, January 17, 2023--PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed"), a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors, and its majority-owned subsidiaries Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or "Lucid Diagnostics"), a commercial-stage cancer prevention diagnostics company, and Veris Health Inc. ("Veris"), a private digital health company focused on enhanced personalized cancer care, today provided a
Business Wire
PAVmed and Lucid Diagnostics to Provide Strategic Business Update
NEW YORK, January 11, 2023--Companies will present refinements to their business strategy as each continue to the benefit patients in need and create value for shareholders.
Business Wire
PAVmed Partners with Novosound on Ultrasound Imaging Technology
NEW YORK, December 22, 2022--PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that it has entered into a license option and joint research and development agreement with Novosound Ltd. ("Novosound"), a venture-backed technology company based in Glasgow, Scotland, to explore applying Novosound’s proprietary flexible thin-film ultrasound technology in me